|
L.V. Tarasova, Yu.V. Tsyganova, I.Yu. Filippov
The role of essential phospholipids in the complex therapy of non-alcoholic fatty liver disease: a case-control study
|
№1 / 2025
|
|
E.Yu. Plotnikova, L.G. Vologzhanina, A.Z. Azanov, A.S. Sukhikh
Comorbidity of liver and biliary tract diseases
|
№1 / 2025
|
|
E.G. Bykova (1), A.L. Petrov (2)
Retrospective analysis of a clinical case of sepsis in a patient with liver cirrhosis
|
№14 / 2020
|
|
E.A. Mezikova, V.D. Zavadovskaya, E.V. Beloborodova, I.V. Dolgalev, O.S. Tonkikh
Multislice computer tomography perfusion imaging of the hepatosplenic zone in patients with diffuse liver diseases
|
№2 / 2019
|
|
T.V. Ermolova (1), E.G. Bykova (1), A.L. Petrov (2), A.O. Nesterko (2)
CLINICAL CASE OF SEVERE PORTOPULMONARY HYPERTENSION IN PATIENT WITH LIVER CYRROSIS OF VIRUS ORIGIN
|
№2 / 2017
|
|
I.G. Bakulin (1), E.V. Vinnitskaya (2), A.V. Polukhina (2), Yu.G. Sandler (2)
LIVER FIBROSIS IN CHRONIC HEPATITIS C: VIEW OF THE PROBLEM IN ERA of INTERFERON-FREE TREATMENT
|
№s5-16 / 2016
|
|
I.G. Bakulin (1), D.T. Abdurakhmanov (2, 3), N.V. Shalikiani (1), A.V. Polukhina (1), Yu.A. Matveeva (1), E.I. Sidorova (3), T.P. Rozina (2), E.N. Nikulkina (2)
HCV-ASSOCIATED LIVER CIRRHOSIS: MODERN POSSIBILITIES OF INTERFERON-FREE THERAPY (ACCORDING TO THE RESULTS OF PROGRAM OF EARLY ACCESS)
|
№2 / 2016
|
|
Andreev D.N., Maev I.V., Dicheva D.T., Kucheryavy Yu.A., Partsvania-Vinogradova E.V.
ANALYSIS OF INFLUENCE OF LIVER FIBROSIS ON EFFICACY AND SAFETY OF ANTI-HELICOBACTER THERAPY
|
№20 / 2015
|
|
A.N. Surkov
MODERN POTENTIALS FOR THE DIAGNOSIS AND TREATMENT OF LIVER CIRRHOSIS IN CHILDREN
|
№1 / 2015
|
|
O.N. Minushkin, L.V. Maslovsky, A.A. Frolova
LIVER CIRRHOSES: EPIDEMIOLOGICAL AND PROGNOSTIC ASPECTS
|
№14 / 2013
|
|
A.V. Russkikh
Portal Gastropathy In Chronic Viral Liver Diseases
|
№2 / 2013
|
|
A.V. Russkikh, V.V. Fomin
Hepatic Encephalopathy And The Principles Of Its Treatment
|
№13 / 2012
|
Русский
